J&J’s Tremfya superior to Stelara in Phase II/III Crohn’s disease trial
Tremfya was superior to both Stelara and placebo in all endoscopic endpoints in the Phase III portion of the Galaxi programme.
22 May 2024
22 May 2024
Tremfya was superior to both Stelara and placebo in all endoscopic endpoints in the Phase III portion of the Galaxi programme.
Data shows the industry is turning towards decentralization to study the effects of drugs in older populations, but how can Decentralized Clinical Trials (DCTs) be implemented in a suitable, age-appropriate way?
The study will take place at Harvard’s Brigham and Women's Hospital and will validate AiM’s robot for deep brain stimulation in Parkinson’s.
Mirikizumab demonstrated significant improvements in Crohn's disease patients.
SonarMD's digital platform uses predictive analytics to identify clinical deterioration in IBD patients before they become emergencies.
The study is designed to assess the safety, toxicity, pharmacokinetics, and preliminary efficacy of BTX-A51.
The trial will be conducted at roughly 200 sites in 22 countries across four continents.
The company secured $35m in financing to support IGV-001’s clinical development.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.